UiPath (NYSE:PATH) Shares Down 1.1% Following Insider Selling

Shares of UiPath, Inc. (NYSE:PATH) dropped 1.1% on Tuesday after an insider sold shares in the company. The stock traded as low as $16.63 and last traded at $16.6690. Approximately 21,407,926 shares were traded during mid-day trading, an increase of 35% from the average daily volume of 15,805,548 shares. The stock had previously closed at $16.85.

Specifically, CEO Daniel Dines sold 45,000 shares of the company’s stock in a transaction on Monday, December 29th. The stock was sold at an average price of $16.44, for a total value of $739,800.00. Following the completion of the sale, the chief executive officer directly owned 28,568,585 shares in the company, valued at $469,667,537.40. This represents a 0.16% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Daniel Dines sold 45,000 shares of the stock in a transaction on Friday, December 26th. The stock was sold at an average price of $16.90, for a total transaction of $760,500.00. Following the completion of the sale, the chief executive officer directly owned 28,613,585 shares of the company’s stock, valued at approximately $483,569,586.50. This trade represents a 0.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In other UiPath news, CEO Daniel Dines sold 45,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 24th. The stock was sold at an average price of $16.91, for a total value of $760,950.00. Following the completion of the transaction, the chief executive officer directly owned 28,658,585 shares in the company, valued at $484,616,672.35. This represents a 0.16% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on PATH. Canaccord Genuity Group lifted their price objective on shares of UiPath from $15.00 to $19.00 and gave the stock a “buy” rating in a research note on Thursday, December 4th. DA Davidson boosted their target price on shares of UiPath from $12.00 to $15.00 and gave the company a “neutral” rating in a research note on Thursday, December 4th. Evercore ISI increased their price objective on UiPath from $15.00 to $17.00 and gave the stock an “in-line” rating in a research note on Thursday, December 4th. Mizuho boosted their price target on shares of UiPath from $14.00 to $15.00 and gave the company a “neutral” rating in a report on Thursday, December 4th. Finally, Wall Street Zen cut UiPath from a “strong-buy” rating to a “buy” rating in a research note on Saturday, December 6th. One research analyst has rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $16.00.

Key Stores Impacting UiPath

Here are the key news stories impacting UiPath this week:

• Positive Sentiment: Morgan Stanley raised its price target on UiPath to $19 (from $15) after the company’s strong FQ3 results and a profitability milestone, giving institutional investors a more constructive valuation backdrop. Morgan Stanley upgrade
• Positive Sentiment: Coverage highlights UiPath’s AI-driven automation momentum, strong cash position and enterprise adoption versus peers — a fundamental narrative that supports longer‑term growth expectations. Zacks comparison
• Positive Sentiment: UiPath’s platform continues to get visibility in AI roundups (e.g., Forbes list of AI agent platforms), reinforcing its market position as enterprises evaluate automation + AI solutions. Forbes feature
• Neutral Sentiment: UiPath has been a trending stock on financial sites lately — increased retail/institutional attention can boost volatility but does not directly imply direction. Zacks trending piece
• Neutral Sentiment: A reminder to watch Jan. 2 (item flagged in media) for any scheduled announcements or market events that could move the stock; impact is unclear until details are released. MSN calendar note
• Negative Sentiment: CEO Daniel Dines has executed multiple stock sales in December (reports show 90,000 shares sold over two days worth roughly $1.5M and a series of similar trades across the month). Those repeated insider dispositions are the most visible near‑term negative catalyst pressuring sentiment and likely contributing to today’s pullback. Fool: CEO selling
• Negative Sentiment: Detailed SEC/insider‑trade filings and MarketBeat summaries show many sequential sales by Dines in December — repeated insider selling can prompt shorter‑term investor caution even with healthy fundamentals. SEC filing / MarketBeat

UiPath Trading Down 1.1%

The firm has a market cap of $8.91 billion, a price-to-earnings ratio of 39.69, a P/E/G ratio of 5.09 and a beta of 1.10. The stock’s fifty day moving average price is $15.55 and its 200-day moving average price is $13.58.

UiPath (NYSE:PATH) last announced its earnings results on Wednesday, December 3rd. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.02. UiPath had a return on equity of 3.73% and a net margin of 14.79%.The company had revenue of $411.11 million for the quarter, compared to analyst estimates of $392.46 million. During the same quarter in the previous year, the company earned $0.11 earnings per share. The firm’s quarterly revenue was up 15.9% compared to the same quarter last year. Analysts predict that UiPath, Inc. will post -0.17 earnings per share for the current year.

Institutional Investors Weigh In On UiPath

Several hedge funds have recently modified their holdings of PATH. Twin Peaks Wealth Advisors LLC acquired a new position in shares of UiPath during the 2nd quarter worth $28,000. AdvisorNet Financial Inc boosted its holdings in UiPath by 320.4% during the second quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company’s stock worth $32,000 after buying an additional 1,887 shares in the last quarter. GAMMA Investing LLC grew its position in UiPath by 48.0% during the second quarter. GAMMA Investing LLC now owns 2,989 shares of the company’s stock worth $38,000 after buying an additional 969 shares during the period. IFP Advisors Inc increased its holdings in UiPath by 508.0% in the second quarter. IFP Advisors Inc now owns 3,283 shares of the company’s stock valued at $42,000 after buying an additional 2,743 shares in the last quarter. Finally, Bayforest Capital Ltd grew its holdings in shares of UiPath by 852.4% in the 2nd quarter. Bayforest Capital Ltd now owns 4,143 shares of the company’s stock worth $53,000 after acquiring an additional 3,708 shares during the period. 62.50% of the stock is owned by institutional investors and hedge funds.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.